CFO
Callan Family Office Portfolio holdings
AUM
$4.65B
1-Year Est. Return
26%
This Fund
S&P 500
1 Year Est. Return
+26%
AUM
$4.65B
AUM Growth
+$1.52B
(+48%)
Holding
1,130
Top Buys
| 1 | +$109M | |
| 2 | +$68.2M | |
| 3 | +$43.4M | |
| 4 |
Microsoft
MSFT
|
+$35.4M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$31.5M |
Top Sells
| 1 | +$3.75M | |
| 2 | +$2.66M | |
| 3 | +$2.58M | |
| 4 |
International Flavors & Fragrances
IFF
|
+$2.18M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$1.91M |
Sector Composition
| 1 | Technology | 22.93% |
| 2 | Financials | 13.2% |
| 3 | Healthcare | 9.15% |
| 4 | Industrials | 7.57% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Costco
COST
$446B
| $16.4M | 0.35% |
19,070
+1,120
|
|
||
52
Oracle
ORCL
$436B
| $15.7M | 0.34% |
80,577
+23,353
|
|
||
53
iShares Core S&P Total US Stock Market ETF
ITOT
$81.4B
| $15.3M | 0.33% |
103,148
-1,679
|
|
||
54
Abbott
ABT
$196B
| $15.1M | 0.32% |
120,588
+27,924
|
|
||
55
Micron Technology
MU
$438B
| $14.7M | 0.32% |
51,382
+17,476
|
|
||
56
ServiceNow
NOW
$128B
| $14.5M | 0.31% |
94,763
+24,993
|
|
||
57
Novartis
NVS
$311B
| $14.5M | 0.31% |
104,847
+16,872
|
|
||
58
Vanguard FTSE Developed Markets ETF
VEA
$206B
| $14.2M | 0.31% |
227,480
+134,730
|
|
||
|
MRSH
59
Marsh
MRSH
$87.1B
| $14.1M | 0.3% |
76,243
+13,214
|
|
||
60
Bank of New York Mellon
BK
$79.2B
| $14M | 0.3% |
120,975
+12,395
|
|
||
61
GSK
GSK
$111B
| $14M | 0.3% |
285,929
+66,376
|
|
||
62
Johnson & Johnson
JNJ
$585B
| $13.9M | 0.3% |
67,398
+12,878
|
|
||
63
Intuit
INTU
$131B
| $13.9M | 0.3% |
21,003
+5,889
|
|
||
64
Chevron
CVX
$375B
| $13.5M | 0.29% |
88,524
+20,015
|
|
||
65
Applovin
APP
$174B
| $13.5M | 0.29% |
19,970
+9,410
|
|
||
66
AbbVie
ABBV
$402B
| $13.3M | 0.29% |
58,398
+17,044
|
|
||
67
iShares MSCI ACWI ex US ETF
ACWX
$8.96B
| $13.3M | 0.28% |
197,582
+150,616
|
|
||
68
Vanguard Total International Stock ETF
VXUS
$132B
| $13.1M | 0.28% |
173,360
+31,569
|
|
||
69
Gilead Sciences
GILD
$182B
| $13M | 0.28% |
105,870
+17,592
|
|
||
70
Advanced Micro Devices
AMD
$330B
| $12.8M | 0.27% |
59,634
+22,961
|
|
||
71
CVS Health
CVS
$99.6B
| $12.3M | 0.26% |
155,304
+19,988
|
|
||
72
Vanguard FTSE Emerging Markets ETF
VWO
$110B
| $12.3M | 0.26% |
228,175
+35,152
|
|
||
73
FedEx
FDX
$84.9B
| $12.2M | 0.26% |
42,149
+4,318
|
|
||
74
Exxon Mobil
XOM
$627B
| $12.1M | 0.26% |
100,892
+24,214
|
|
||
75
AstraZeneca
AZN
$302B
| $11.9M | 0.26% |
129,133
+86,453
|
|